Citigroup
TAK icon

Citigroup’s Takeda Pharmaceutical TAK Stock Holding History

Citigroup’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-886,780
Closed -$16.1M – 7325
2020
Q4 		$16.1M Sell
886,780
-21,800
-2% -$382K 0.01% 1191
2020
Q3 		$16.2M Sell
908,580
-67,200
-7% -$1.22M 0.01% 1025
2020
Q2 		$17.5M Buy
975,780
+42,100
+5% +$756K 0.01% 908
2020
Q1 		$14.2M Sell
933,680
-143,162
-13% -$2.59M 0.01% 936
2019
Q4 		$21.2M Buy
1,076,842
+110,985
+11% +$2.12M 0.02% 939
2019
Q3 		$16.6M Sell
965,857
-168,961
-15% -$2.92M 0.01% 1039
2019
Q2 		$20.1M Sell
1,134,818
-168,859
-13% -$3.07M 0.02% 924
2019
Q1 		$26.6M Buy
+1,303,677
New +$26.2M 0.03% 687

Other funds holding TAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Ethic Inc
Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Hantz Financial Services
Hantz Financial Services Southfield, Michigan $7.48B AUM 14.09% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Citigroup's TAK Position: Q3 2026 in Review

Citigroup reduced its Takeda Pharmaceutical (TAK) stake by 24% in Q3 2026, selling an estimated $1.7M and leaving 300,375 shares worth $5.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2052.

Citigroup first reported a position in TAK in Q4 2018 and has held it in 32 quarters since. The position peaked at $113M in Q4 2018. 243 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Citigroup held 300,375 shares of Takeda Pharmaceutical worth $5.46M as of Q3 2026.
  • Citigroup sold 96,082 Takeda Pharmaceutical shares in Q3 2026, an estimated $1.7M.
  • Takeda Pharmaceutical made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #2052 holding.
  • Citigroup first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 32 quarters since.
  • Citigroup's Takeda Pharmaceutical position peaked at $113M in Q4 2018.
  • 243 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.